Beta-Carotene Testing Is Not Recommended and May Be Harmful
Beta-carotene testing is not recommended for clinical use as it provides no benefit and may lead to harmful supplementation, particularly in smokers where beta-carotene supplementation increases risk of lung cancer and cardiovascular mortality.
Evidence Against Beta-Carotene Testing
The U.S. Preventive Services Task Force (USPSTF) has issued clear recommendations against beta-carotene supplementation, stating that the harms outweigh the benefits for the prevention of cardiovascular disease or cancer 1. This position has been consistently maintained and reinforced in more recent guidelines.
The 2024 American Diabetes Association Standards of Care explicitly states that "the harms of β-carotene outweigh the benefits for the prevention of CVD or cancer. β-Carotene was associated with increased lung cancer and cardiovascular mortality risk" 1. This recommendation is based on the 2022 USPSTF statement.
Similarly, the 2023 American Diabetes Association Standards of Care had already highlighted that "β-carotene was significantly associated with increased lung cancer and cardiovascular mortality risk" 1.
Reasons Why Beta-Carotene Testing Is Not Useful
No clinical utility for supplementation decisions:
- Testing would only identify levels of a substance that has no proven benefit when supplemented
- The USPSTF found "good evidence that β-carotene supplementation provides no benefit in the prevention of cancer or cardiovascular disease in middle-aged and older adults" 1
Potential harm from supplementation:
No established reference range with clinical significance:
- There is no evidence supporting that specific beta-carotene levels correlate with improved health outcomes
- Observational associations between dietary beta-carotene intake and health cannot be translated into supplementation benefits
Historical Context of Beta-Carotene Research
The recommendation against beta-carotene testing and supplementation is based on multiple large clinical trials:
- The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC) showed increased lung cancer risk in smokers taking beta-carotene 2
- The Beta-Carotene and Retinol Efficacy Trial (CARET) similarly showed harm in smokers and asbestos workers 3
- The Physicians' Health Study found no benefit of beta-carotene supplementation over 12 years for cancer, cardiovascular disease, or all-cause mortality 4
- The Women's Health Study also found no benefit from beta-carotene supplementation 5
Alternative Approaches to Consider
Instead of beta-carotene testing, healthcare providers should:
Recommend whole food sources of carotenoids:
- Encourage consumption of fruits and vegetables containing natural carotenoids
- The American Cancer Society emphasizes that "evidence that vegetable and fruit consumption reduces cancer risk has led to attempts to isolate specific nutrients from these foods and study their effects as supplements, sometimes in very high doses. However, many such chemoprevention studies have failed to confirm promising leads, and some even suggested harm" 1
Focus on overall dietary patterns:
Consider vitamin deficiency testing only when clinically indicated:
- Test for specific vitamin deficiencies based on symptoms or risk factors
- Monitor vitamin B12 in patients taking metformin 6
Special Considerations
- Smokers: Explicitly warn against beta-carotene supplementation due to increased lung cancer risk 6
- Patients with kidney disease: Require careful monitoring with any vitamin supplementation due to altered excretion 6
- Patients on medications: Consider potential drug-nutrient interactions before recommending any supplements 6
Beta-carotene testing represents a case where observational studies suggested benefits, but randomized controlled trials demonstrated no benefit and potential harm. This highlights the importance of basing clinical recommendations on the highest quality evidence available.